NSI-189 IND Application for Treatment of Depression, Neuralstem (AMEX:CUR)
November 22nd, 2010
No comments
CUR has filed an Investigational New Drug (IND) application with the FDA to begin 2 Phase I safety trials to test NSI-189, Read more…
Categories: NSI-189 IND Application, Stem Cell Technology
